NCT02660060View on ClinicalTrials.gov

Bioequivalence Study of Two Formulations of Pramipexole Tablets 0.25 mg

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

June 30, 2015

Conditions
Healthy
Interventions
DRUG

Pramipexole Dexa Medica

Pramipexole 0.25 tablets produced by PT Dexa Medica for PT Ferron Par Pharmaceuticals as the test drug.

DRUG

Pramipexole Boehringer Ingelheim Pharma

Pramipexole 0.25 tablets produced by Boehringer Ingelheim Pharma GmbH \& Co.KG for Boehringer Ingelheim International GmbH as the reference drug.

Trial Locations (1)

12430

PT Equilab International, Jakarta

Sponsors

Lead Sponsor

Dexa Medica Group
All Listed Sponsors
lead

Dexa Medica Group

INDUSTRY

NCT02660060 - Bioequivalence Study of Two Formulations of Pramipexole Tablets 0.25 mg | Biotech Hunter | Biotech Hunter